| # | % | |||||
|---|---|---|---|---|---|---|
| 101 | BLUEBIRD BIO INC COM | 293,943 | 19,923,000 | 0.18% | ||
| 102 | ACHILLION PHARMACEUTICALS IN | 2,475,515 | 20,052,000 | 0.18% | ||
| 103 | HALOZYME THERAPEUTICS INC | 1,731,057 | 20,911,000 | 0.19% | ||
| 104 | XENCOR INC COM | 872,072 | 21,357,000 | 0.19% | ||
| 105 | ARRAY BIOPHARMA INC | 3,310,666 | 22,347,000 | 0.20% | ||
| 106 | FOAMIX PHARMACEUTICALS LTD | 2,466,702 | 22,842,000 | 0.21% | ||
| 107 | Progenics Pharmaceuticals Inc | 3,650,808 | 23,110,000 | 0.21% | ||
| 108 | VERSARTIS INC | 2,134,247 | 26,145,000 | 0.24% | ||
| 109 | ADVANCED ACCELERATOR APPLIC | 1,029,247 | 39,194,000 | 0.36% | ||
| 110 | NEUROCRINE BIOSCIE COM USD0.001 | 895,422 | 45,344,000 | 0.41% | ||
| 111 | BIOCRYST PHARMACEUTICALS | 10,963,944 | 48,351,000 | 0.44% | ||
| 112 | HERON THERAPEUTICS INC COM | 2,857,250 | 49,230,000 | 0.45% | ||
| 113 | INVITAE CORP | 6,554,967 | 57,422,000 | 0.52% | ||
| 114 | BEIGENE LTD | 1,912,680 | 58,930,000 | 0.53% | ||
| 115 | ACORDA THERAPEUTICS INC | 77,083,000 | 62,830,000 | 0.57% | PRN | |
| 116 | EXELIXIS INC | 4,929,494 | 63,048,000 | 0.57% | ||
| 117 | AMARIN CORP PLC | 20,630,477 | 65,811,000 | 0.60% | ||
| 118 | CLOVIS ONCOLOGY INC | 72,758,000 | 69,135,000 | 0.63% | PRN | |
| 119 | ACORDA THERAPEUTICS INC | 3,661,082 | 76,443,000 | 0.69% | ||
| 120 | SPARK THERAPEUTICS INCORPORATED | 1,318,341 | 79,180,000 | 0.72% | ||
| 121 | CERUS CORP | 13,053,275 | 81,061,000 | 0.74% | ||
| 122 | BELLICUM PHARMACEUTICALS INCORPORATED | 4,865,647 | 96,826,000 | 0.88% | ||
| 123 | BIOMARIN PHARMACEUTICAL INC SR SB CV1.875 17 | 22,379,000 | 101,405,000 | 0.92% | PRN | |
| 124 | AQUINOX PHARMACEUTICALS INC | 10,536,092 | 140,762,000 | 1.28% | ||
| 125 | DBV TECHNOLOGIES S A | 5,509,560 | 200,162,000 | 1.82% | ||
| 126 | GENOMIC HEALTH INC COM | 13,770,302 | 398,237,000 | 3.61% | ||
| 127 | BIOMARIN PHARMACEUTICAL INC | 4,806,483 | 444,696,000 | 4.04% | ||
| 128 | Incyte Corporation | 259,000,000 | 491,344,000 | 4.46% | PRN | |
| 129 | Incyte Corporation | 274,500,000 | 531,244,000 | 4.82% | PRN | |
| 130 | ALEXION PHARMACEUTIC | 6,543,295 | 801,815,000 | 7.28% | ||
| 131 | ACADIA PHARMACEUTICALS INC COM | 25,819,768 | 821,327,000 | 7.45% | ||
| 132 | ABBVIE INC | 14,343,358 | 904,636,000 | 8.21% | ||
| 133 | INCYTE CORP | 23,498,898 | 2,215,711,000 | 20.11% | ||
| 134 | SEATTLE GENETICS INC | 44,100,294 | 2,381,857,000 | 21.61% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-16-134352, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
